These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 34437574)
1. Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease. Choi Y; Sim S; Lee DH; Lee HR; Ban GY; Shin YS; Kim YK; Park HS PLoS One; 2021; 16(8):e0256237. PubMed ID: 34437574 [TBL] [Abstract][Full Text] [Related]
2. Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease. Choi Y; Lee DH; Trinh HKT; Ban GY; Park HK; Shin YS; Kim SH; Park HS Allergy; 2019 Jan; 74(1):78-88. PubMed ID: 29663427 [TBL] [Abstract][Full Text] [Related]
3. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma. Yamaguchi T; Ishii T; Yamamoto K; Higashi N; Taniguchi M; Okamoto M Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517 [TBL] [Abstract][Full Text] [Related]
4. Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease. Trinh HKT; Pham DL; Choi Y; Kim HM; Kim SH; Park HS Clin Exp Allergy; 2018 Nov; 48(11):1464-1473. PubMed ID: 30126026 [TBL] [Abstract][Full Text] [Related]
5. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879 [TBL] [Abstract][Full Text] [Related]
6. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease. Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538 [TBL] [Abstract][Full Text] [Related]
7. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease. Comhair SAA; Bochenek G; Baicker-McKee S; Wang Z; Stachura T; Sanak M; Hammel JP; Hazen SL; Erzurum SC; Nizankowska-Mogilnicka E Respir Res; 2018 Oct; 19(1):210. PubMed ID: 30376852 [TBL] [Abstract][Full Text] [Related]
8. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD. Choi GS; Kim JH; Shin YS; Ye YM; Kim SH; Park HS Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280 [TBL] [Abstract][Full Text] [Related]
9. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. Kawagishi Y; Mita H; Taniguchi M; Maruyama M; Oosaki R; Higashi N; Kashii T; Kobayashi M; Akiyama K J Allergy Clin Immunol; 2002 Jun; 109(6):936-42. PubMed ID: 12063521 [TBL] [Abstract][Full Text] [Related]
10. Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease. Ban GY; Cho K; Kim SH; Yoon MK; Kim JH; Lee HY; Shin YS; Ye YM; Cho JY; Park HS Clin Exp Allergy; 2017 Jan; 47(1):37-47. PubMed ID: 27533637 [TBL] [Abstract][Full Text] [Related]
11. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease. Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637 [TBL] [Abstract][Full Text] [Related]
12. Biological effects of leukotriene E4 on eosinophils. Steinke JW; Negri J; Payne SC; Borish L Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):105-10. PubMed ID: 24768603 [TBL] [Abstract][Full Text] [Related]
13. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity. Liu T; Barrett NA; Kanaoka Y; Yoshimoto E; Garofalo D; Cirka H; Feng C; Boyce JA J Immunol; 2018 Feb; 200(3):915-927. PubMed ID: 29282304 [TBL] [Abstract][Full Text] [Related]
14. Factors driving the aspirin exacerbated respiratory disease phenotype. Steinke JW; Borish L Am J Rhinol Allergy; 2015; 29(1):35-40. PubMed ID: 25590316 [TBL] [Abstract][Full Text] [Related]
16. Update on recent advances in the management of aspirin exacerbated respiratory disease. Palikhe NS; Kim JH; Park HS Yonsei Med J; 2009 Dec; 50(6):744-50. PubMed ID: 20046412 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma. Bochenek G; Stachura T; Szafraniec K; Plutecka H; Sanak M; Nizankowska-Mogilnicka E; Sladek K J Allergy Clin Immunol Pract; 2018; 6(2):528-535. PubMed ID: 28888846 [TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort. Lee Y; Kim C; Lee E; Lee HY; Woo SD; You SC; Park RW; Park HS Clin Exp Allergy; 2023 Sep; 53(9):941-950. PubMed ID: 37332228 [TBL] [Abstract][Full Text] [Related]
19. Persistent Eosinophilic Inflammation in Adult Asthmatics with High Serum and Urine Levels of Leukotriene E Ban GY; Kim SH; Park HS J Asthma Allergy; 2021; 14():1219-1230. PubMed ID: 34675552 [TBL] [Abstract][Full Text] [Related]
20. Eosinophil production of prostaglandin D Feng X; Ramsden MK; Negri J; Baker MG; Payne SC; Borish L; Steinke JW J Allergy Clin Immunol; 2016 Oct; 138(4):1089-1097.e3. PubMed ID: 27423494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]